financetom
Business
financetom
/
Business
/
L3Harris raises top end of 2024 adjusted earnings outlook amid global tensions
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
L3Harris raises top end of 2024 adjusted earnings outlook amid global tensions
Apr 25, 2024 2:14 PM

(Reuters) - L3Harris ( LHX ) lifted the upper-end of its annual adjusted profit target on Thursday, betting on sustained weapons demand and robust defense spending amid escalating global security concerns.

U.S. defense companies are experiencing a surge in contracts as the Russia-Ukraine war, the Middle East crisis and the specter of Chinese aggression are driving demand, but growth is still hindered by pandemic-related labor and supply-chain disruptions.

Following the Aerojet buyout in 2023, L3Harris ( LHX ) suspended its merger and acquisition activity for the "foreseeable future" in efforts to strengthen its balance sheet.

L3Harris ( LHX ) also launched a review of its operational performance, cost structure and portfolio composition, which is expected to be completed by this year.

The company now expects the upper-end of its annual adjusted profit to be $13.05 per share, up from its previous guide of $12.80 per share.

Earlier this week, Reuters reported that L3Harris ( LHX ) would cut 5% of its workforce this year as part of a cost saving measure, citing an email to employees.

Florida-based L3Harris ( LHX ) posted an adjusted profit of $3.06 per share for the quarter ended March 31, compared with $2.86 per share a year earlier.

Its overall sales in the first-quarter rose 17% to $5.2 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BridgeBio Pharma Reports Positive Additional Data From Phase 3 Study of Acoramidis; Shares Rise
BridgeBio Pharma Reports Positive Additional Data From Phase 3 Study of Acoramidis; Shares Rise
Sep 1, 2024
12:02 PM EDT, 08/30/2024 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said Friday that additional data from a phase 3 study of acoramidis in transthyretin amyloid cardiomyopathy or ATTR-CM showed that switching from standard of care treatment and placebo to acoramidis increased serum transthyretin at the first month. The increase in serum transthyretin or TTR was correlated with reduced...
What's Going On With Cingulate Shares Recently?
What's Going On With Cingulate Shares Recently?
Sep 1, 2024
Cingulate Inc. ( CING ) shares are soaring Friday. Last week, the company announced a Precision Timed Release (PTR) technology, designed to enhance ADHD drug delivery. The company’s technology aims to improve the onset and efficacy of existing ADHD treatments. Zacks Small-Cap Research also issued a note with a $70 valuation on the stock earlier this week. Trading Volume: The stock...
Soccer-Man Utd humbled as Diaz double helps Liverpool humiliate rivals
Soccer-Man Utd humbled as Diaz double helps Liverpool humiliate rivals
Sep 1, 2024
MANCHESTER, England, Sept 1 (Reuters) - Two goals from Luis Diaz and one from Mohamed Salah helped Liverpool stroll to a 3-0 victory at Manchester United ( MANU ) in the Premier League on Sunday, with Erik ten Hag's side humbled by their fierce rivals. Liverpool dominated a United team who could not keep pace with them in the first...
China to pitch green tech exports to African leaders as Western curbs loom
China to pitch green tech exports to African leaders as Western curbs loom
Sep 1, 2024
BEIJING/NAIROBI (Reuters) - China will urge a summit of 50 African nations in Beijing this week to take more of its goods, before Western curbs kick in on its exports such as electric vehicles and solar panels, in exchange for more pledges of loans and investment. But the dozens of African leaders arriving in the Chinese capital for the three-yearly...
Copyright 2023-2026 - www.financetom.com All Rights Reserved